Last update 06 Jan 2026

Insulin degludec/Insulin aspart(Federal Biotechnology (Zhuhai Hengqin))

Overview

Basic Info

Drug Type
Peptide Hormone
Synonyms-
Target
INSR
Action
agonists
Mechanism
INSR agonists(Insulin receptor agonists)
Therapeutic Areas
Endocrinology and Metabolic Disease
Active Indication
Diabetes Mellitus, Type 2
Inactive Indication-
Originator Organization
The United Bio-Technology(Hengqin) Co., Ltd.
Active Organization
The United Bio-Technology(Hengqin) Co., Ltd.Zhuhai United Pharmaceutical Co.,Ltd.Zhuhai United Pharmaceutical Co.,Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Related

2
Clinical Trials associated with Insulin degludec/Insulin aspart(Federal Biotechnology (Zhuhai Hengqin))
CTR20242041
/ CompletedPhase 1
随机、开放、两周期、自身交叉对照设计，评价德谷门冬双胰岛素注射液与“诺和佳®”在中国健康受试者中的药代动力学和安全性比对试验
[Translation] A randomized, open-label, two-period, self-crossover controlled trial to evaluate the pharmacokinetics and safety of degludec and insulin aspart injection versus Novogar® in healthy Chinese subjects
CTR20255168
/ Not yet recruitingPhase 3
多中心、随机、开放、阳性对照的Ⅲ期临床试验比较联邦生物德谷门冬双胰岛素和诺和佳®治疗2型糖尿病的有效性和安全性
[Translation] A multicenter, randomized, open-label, positive-controlled phase III clinical trial compared the efficacy and safety of Degludec-Aspart dual insulin and Novogene® in the treatment of type 2 diabetes.
100 Clinical Results associated with Insulin degludec/Insulin aspart(Federal Biotechnology (Zhuhai Hengqin))
Login to view more data
100 Translational Medicine associated with Insulin degludec/Insulin aspart(Federal Biotechnology (Zhuhai Hengqin))
Login to view more data
100 Patents (Medical) associated with Insulin degludec/Insulin aspart(Federal Biotechnology (Zhuhai Hengqin))
Login to view more data
100 Deals associated with Insulin degludec/Insulin aspart(Federal Biotechnology (Zhuhai Hengqin))
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Diabetes Mellitus, Type 2Phase 3
China
The United Bio-Technology(Hengqin) Co., Ltd.
06 Jan 2026
Diabetes Mellitus, Type 2Phase 3
China
Zhuhai United Pharmaceutical Co.,Ltd.Zhuhai United Pharmaceutical Co.,Ltd.
06 Jan 2026
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free